INS and type 1 diabetes mellitus: The INHALE-3 study is a Phase 4 randomized controlled trial evaluating the efficacy and safety of inhaled insulin Afrezza combined with insulin Degludec (Novo Nordisk, Bagsværd, Denmark) versus usual care in adults with Type I diabetes.